The world has been shaken by SARS-Cov-19 leading to a complete disruption in healthcare services. SurgEase is proud to have been awarded funding by the UK Government to deliver tele-endoscopy in community settings, allowing patients with complex GI-disease and cancer, to continue receiving high quality care through precision endo-luminal diagnostics, and digital access to specialists in secondary care.
SurgEase’s technology will future-proof the NHS to withstand further waves of infection, and pave the way for new ways of delivering cost-efficient and timely care to its patients.
Funded by Innovate UK
